Medicine recalls
|
| |
| Batch recall of Rocephin for Injection 1G IV Sterile Powder |
| |
The Department of Health (DH) today (30 June) endorsed a licensed wholesaler, Roche Hong Kong Limited (Roche), to recall one batch (batch number B0746B02) of Rocephin for Injection 1G IV Sterile Powder (Hong Kong Registration number HK-20190) from the market due to a potential quality defect of the product.
The DH received notification from Roche that the overseas packaging unit of Roche had detected pinholes in some of the 10ml Water for Injection ampoules attached to the product. The pinholes were considered melting defects during the production of the ampoules. As a precautionary measure, Roche voluntarily recall the affected batch from the market. DH's investigation is continuing.
The above product, containing ceftriaxone, is a prescription medicine used for treatment of infections. According to Roche, the affected batch has been supplied to private hospitals, private doctors and re-exported to Macau.
So far, the DH has not received any adverse drug reaction report related to the affected product.
Roche has set up a hotline 2895 9531 to answer related enquiries. The DH will closely monitor the recall.
Ends/Thursday, June 30, 2022 |
| |
